• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Is F45 Training Holdings Down By 56%? Here Are 28 Stocks Moving In Wednesday's Pre-Market Session

    7/27/22 6:34:56 AM ET
    $ACRX
    $AIM
    $AYLA
    $DAVE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ACRX alert in real time by email

    Gainers

    • Dave Inc. (NASDAQ:DAVE) rose 56.9% to $0.9826 in pre-market trading. Dave is expected to release its second quarter 2022 financial results on Thursday, August 11, 2022.
    • Pzena Investment Management, Inc (NYSE:PZN) rose 46.4% to $9.43 in pre-market trading as the company said it has entered into an agreement to become a private company. The company also reported a rise quarterly sales.
    • Teva Pharmaceutical Industries Limited (NYSE:TEVA) rose 18.3% to $8.42 in pre-market trading after the company reported better-than-expected financial results.
    • Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) rose 18.1% to $0.31 in pre-market trading after declining more than 9% on Tuesday.
    • AIM ImmunoTech Inc. (NYSE:AIM) rose 16.4% to $0.8380 in pre-market trading. AIM ImmunoTech recently reported follow-on data from its published single-center named patient program.
    • GeoVax Labs, Inc. (NASDAQ:GOVX) rose 15.7% to $1.97 in pre-market trading. GeoVax Labs is expected to report second quarter 2022 financial results on Wednesday, August 3, 2022.
    • Imperial Petroleum Inc. (NASDAQ:IMPP) rose 14.4% to $0.5601 in pre-market trading after jumping around 15% on Tuesday.
    • Stronghold Digital Mining, Inc. (NASDAQ:SDIG) rose 12.8% to $2.65 in pre-market trading after declining 7% on Tuesday.
    • Ebang International Holdings Inc. (NASDAQ:EBON) rose 12.2% to $0.50 in pre-market trading after dropping 11% on Tuesday.
    • AgEagle Aerial Systems, Inc. (NASDAQ:UAVS) rose 11.3% to $0.68 in pre-market trading after dropping more than 6% on Tuesday.
    • Western Midstream Partners, LP (NYSE:WES) rose 11.1% to $29.46 in pre-market trading. Western Midstream Partners recently announced that the board of directors of its general partner declared a quarterly cash distribution of $0.50 per unit for the second quarter.
    • VNET Group, Inc. (NASDAQ:VNET) rose 10.8% to $5.23 in pre-market trading after Bloomberg reported that MBK Partners is considering making a bid for the company.
    • Enphase Energy, Inc. (NASDAQ:ENPH) shares rose 9.9% to $237.50 in pre-market trading after the company reported better-than-expected Q2 EPS and sales results and issued Q3 revenue guidance above analyst estimates.
    • Nutriband Inc. (NASDAQ:NTRB) rose 9.5% to $7.15 in pre-market trading. Nutriband shares jumped over 28% on Tuesday after the company received final judgement in its favor, allowing the company to cancel 1.2 million shares outstanding.
    • BitNile Holdings, Inc. (NYSE:NILE) rose 9.4% to $0.3099 in pre-market trading after dropping around 8% on Tuesday.
    • MacroGenics, Inc. (NASDAQ:MGNX) rose 9.1% to $3.98 in pre-market trading. MacroGenics is expected to release its Q2 financial results on Monday, August 8, 2022.
    • Microsoft Corporation (NASDAQ:MSFT) rose 3.7% to $261.20 in pre-market trading. Microsoft reported weaker-than-expected results for its fourth quarter on Tuesday. However, the company issued an upbeat sales outlook for the fiscal year.
    • Alphabet Inc. (NASDAQ:GOOGL) rose 3.5% to $108.68 in pre-market trading. Alphabet reported downbeat earnings for its second quarter on Tuesday. However, revenue for the company’s Search and Other segment was $40.7 billion, up 13.7% year-over-year.


    Don’t forget to check out our premarket coverage here .

    Losers

    • ObsEva SA (NASDAQ:OBSV) shares fell 76.1% to $0.3850 in pre-market trading after the company announced plans to initiate a corporate restructuring and refocus the Company’s development and commercialization strategy.
    • F45 Training Holdings Inc. (NASDAQ:FXLV) fell 55.8% to $1.55 in pre-market trading after the company cut its FY22 sales guidance to below analyst estimates. Macquarie downgraded F45 Training from Outperform to Neutral and lowered the price target from $17 to $4.
    • Cassava Sciences, Inc. (NASDAQ:SAVA) fell 48.2% to $11.22 in pre-market trading. The U.S. Justice Department has opened a criminal investigation into Cassava Sciences tied to its experimental Alzheimer's drug, Reuters reported.
    • Ayala Pharmaceuticals, Inc. (NASDAQ:AYLA) shares fell 10.1% to $1.52 in pre-market trading. Ayala Pharmaceuticals shares jumped 94% on Tuesday after the company filed a request for the withdrawal of the Registration Statement on Form S-1.
    • Pagaya Technologies Ltd. (NASDAQ:PGY) fell 8.5% to $15.30 in pre-market trading. Pagaya Technologies shares jumped 73% on Tuesday on continued volatility after the company completed its SPAC merger agreement last month.
    • AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) shares fell 8.6% to $0.1919 in pre-market trading after dropping over 6% on Tuesday.
    • IMAC Holdings, Inc. (NASDAQ:IMAC) fell 8.4% to $0.8720 in pre-market trading. IMAC Holdings recently announced exploration of strategic alternatives to maximize shareholder value.
    • Freight Technologies, Inc. (NASDAQ:FRGT) fell 7.7% to $2.29 in pre-market trading. Freight Technologies shares jumped around 68% on Tuesday after the company announced it was awarded Samsung Mexico SDS business and has begun using its platform to assist with effecting Samsung's shipments from Mexico to the United States.
    • AMTD Digital Inc. (NYSE:HKD) fell 7.5% to $52.04 in pre-market trading after jumping around 28% on Tuesday.
    • Versus Systems Inc. (NASDAQ:VS) shares fell 7.4% to $0.5001 in pre-market trading. Versus Systems shares jumped around 20% on Tuesday after the USPTO issued U.S. Patent No. 11,376,498 to the company to cover games and challenges that produce real world rewards inside of apps and streaming media.
    Get the next $ACRX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACRX
    $AIM
    $AYLA
    $DAVE

    CompanyDatePrice TargetRatingAnalyst
    Alphabet Inc.
    $GOOGL
    2/23/2026$387.00Equal Weight → Overweight
    Wells Fargo
    GeoVax Labs Inc.
    $GOVX
    2/19/2026Buy → Hold
    D. Boral Capital
    Microsoft Corporation
    $MSFT
    2/9/2026Buy → Hold
    Melius
    Dave Inc.
    $DAVE
    2/9/2026Outperform
    Keefe Bruyette
    Microsoft Corporation
    $MSFT
    2/5/2026$392.00Buy → Hold
    Stifel
    Enphase Energy Inc.
    $ENPH
    2/4/2026$52.00Hold → Buy
    HSBC Securities
    Enphase Energy Inc.
    $ENPH
    2/4/2026$41.00Underperform → Market Perform
    BMO Capital Markets
    Enphase Energy Inc.
    $ENPH
    2/4/2026$54.00Sector Perform → Outperform
    RBC Capital Mkts
    More analyst ratings

    $ACRX
    $AIM
    $AYLA
    $DAVE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Stanton John W bought $1,986,750 worth of shares (5,000 units at $397.35), increasing direct ownership by 6% to 83,905 units (SEC Form 4)

    4 - MICROSOFT CORP (0000789019) (Issuer)

    2/18/26 6:14:22 PM ET
    $MSFT
    Computer Software: Prepackaged Software
    Technology

    President & CEO Kothandaraman Badrinarayanan bought $259,884 worth of shares (5,000 units at $51.98) (SEC Form 4)

    4 - Enphase Energy, Inc. (0001463101) (Issuer)

    2/5/26 4:41:25 PM ET
    $ENPH
    Semiconductors
    Technology

    Vice Chair and President Smith Bradford L bought $1,450,221 worth of shares (3,842 units at $377.46) and sold $1,684,498 worth of shares (3,842 units at $438.44) (SEC Form 4)

    4 - MICROSOFT CORP (0000789019) (Issuer)

    12/12/25 6:20:17 PM ET
    $MSFT
    Computer Software: Prepackaged Software
    Technology

    $ACRX
    $AIM
    $AYLA
    $DAVE
    SEC Filings

    View All

    Cassava Sciences Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - CASSAVA SCIENCES INC (0001069530) (Filer)

    2/19/26 8:15:27 AM ET
    $SAVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by Western Midstream Partners LP

    10-K - Western Midstream Partners, LP (0001423902) (Filer)

    2/18/26 5:20:02 PM ET
    $WES
    Natural Gas Distribution
    Utilities

    Western Midstream Partners LP filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Western Midstream Partners, LP (0001423902) (Filer)

    2/18/26 5:17:41 PM ET
    $WES
    Natural Gas Distribution
    Utilities

    $ACRX
    $AIM
    $AYLA
    $DAVE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Savage Brian claimed ownership of 739 units of Ordinary Shares (SEC Form 3)

    3 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)

    2/23/26 4:17:10 PM ET
    $TEVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: President and CIO Porat Ruth covered exercise/tax liability with 47,141 units of Class C Capital Stock and was granted 94,715 units of Class C Capital Stock, increasing direct ownership by 20% to 862,377 units (SEC Form 4)

    4/A - Alphabet Inc. (0001652044) (Issuer)

    2/20/26 6:27:06 PM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    Amendment: SVP, Chief Business Officer Schindler Philipp was granted 227,313 units of Class C Capital Stock and covered exercise/tax liability with 113,745 units of Class C Capital Stock, increasing direct ownership by 15% to 886,939 units (SEC Form 4)

    4/A - Alphabet Inc. (0001652044) (Issuer)

    2/20/26 5:56:10 PM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    $ACRX
    $AIM
    $AYLA
    $DAVE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial

    ROCKVILLE, MD, Feb. 23, 2026 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that the U. S. Food and Drug Administration (FDA) has placed a partial clinical hold on its Phase 2 LINNET study of lorigerlimab, an investigational, bispecific DART® molecule that targets PD-1 and CTLA-4, in patients with gynecologic cancers. Under the partial clinical hold, no new patients will be enrolled in the LINNET study until the partial hold is lifted by the FDA. Current study participants may continue to receive study drug. The FDA's partial clinical

    2/23/26 6:14:00 PM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    AIM ImmunoTech Announces Planned Milestones in the Ongoing Phase 2 Trial of Ampligen and AstraZeneca's Durvalumab in the Treatment of Metastatic Pancreatic Cancer

    OCALA, Fla., Feb. 23, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company") today announced milestones in the expected timeline for the ongoing Phase 2 clinical study evaluating AIM's drug Ampligen® (rintatolimod) combined with AstraZeneca's anti-PD-L1 immune checkpoint inhibitor Imfinzi® (durvalumab) in the treatment of metastatic pancreatic cancer patients with stable disease post-FOLFIRINOX standard of care (the "DURIPANC" study) (see: ClinicalTrials.gov NCT05927142). DURIPANC is an investigator-initiated, exploratory, open-label, single-center study, and 18 subjects have enrolled in the study so far. The clinical trial is a joint collaboration between AIM, A

    2/23/26 8:55:00 AM ET
    $AIM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    TGE's Film "Scare Out" Exceeds US$120 Million at the Box Office in just 7 Days

    PARIS, NEW YORK and LONDON, Feb. 23, 2026 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group (NYSE:AMTD, SGX: HKB)), AMTD Digital Inc. (NYSE:HKD) and The Generation Essentials Group (", TGE", , NYSE:TGE, LSE: TGE), a subsidiary of AMTD Digital Inc., jointly announce that "Scare Out" (the "Movie"), the first ever national‑security film co‑produced by TGE, captured a significant share of the box office during the Chinese New Year window. Featuring an all‑star cast including Jackson Yee, Yilong Zhu, Jia Song, Jiayin Lei, Mi Yang, Yi Zhang, Cecilia Liu, and Yaowen Liu, the Movie achieved box office inflows of over US$120 million within just its first seven days of release.

    2/23/26 8:20:00 AM ET
    $AMTD
    $HKD
    $TGE
    Finance: Consumer Services
    Finance
    Newspapers/Magazines
    Consumer Discretionary

    $ACRX
    $AIM
    $AYLA
    $DAVE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for MARGENZA issued to MACROGENICS INC

    Submission status for MACROGENICS INC's drug MARGENZA (SUPPL-5) with active ingredient MARGETUXIMAB-CMKB has changed to 'Approval' on 05/25/2023. Application Category: BLA, Application Number: 761150, Application Classification:

    5/29/23 4:45:45 AM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for MARGENZA

    Submission status for MACROGENICS INC's drug MARGENZA (ORIG-1) with active ingredient MARGETUXIMAB-CMKB has changed to 'Approval' on 12/16/2020. Application Category: BLA, Application Number: 761150, Application Classification:

    12/20/20 4:31:01 PM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACRX
    $AIM
    $AYLA
    $DAVE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Alphabet A upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Alphabet A from Equal Weight to Overweight and set a new price target of $387.00

    2/23/26 8:28:41 AM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    GeoVax Labs downgraded by D. Boral Capital

    D. Boral Capital downgraded GeoVax Labs from Buy to Hold

    2/19/26 8:44:06 AM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Microsoft downgraded by Melius

    Melius downgraded Microsoft from Buy to Hold

    2/9/26 9:08:06 AM ET
    $MSFT
    Computer Software: Prepackaged Software
    Technology

    $ACRX
    $AIM
    $AYLA
    $DAVE
    Financials

    Live finance-specific insights

    View All

    Western Midstream Announces Record Fourth-Quarter and Full-Year 2025 Results

    Announces 2026 Financial GuidanceReported fourth-quarter 2025 Net income attributable to limited partners of $187.2 million, generating record fourth-quarter Adjusted EBITDA(1) of $635.6 million, which included $29.5 million of unfavorable non-cash revenue adjustments.Reported full-year 2025 Net income attributable to limited partners of $1.154 billion, generating record full-year Adjusted EBITDA(1) of $2.481 billion, exceeding the midpoint of the full-year 2025 Adjusted EBITDA guidance range of $2.350 billion to $2.550 billion, and representing a 6-percent year-over-year increase.Reported fourth-quarter 2025 Cash flows provided by operating activities of $557.6 million, generating fourth-qu

    2/18/26 4:05:00 PM ET
    $WES
    Natural Gas Distribution
    Utilities

    EagleNXT Announces Strategic Procurement in Malaysia

    Malaysian Government Customer Acquires eBee TAC Tactical Drone and eBee X Sustainment Package to Increase Capability and Boost Mission Readiness ALLEN, Texas, Feb. 12, 2026 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (dba, EagleNXT) (the "Company" or "EagleNXT") (NYSE:UAVS), a leading provider of full stack drone, sensors, and software solutions for customers worldwide in the commercial and government verticals, today announced a procurement of an eBee TAC drone by an agency within the Malaysian government. The acquisition, facilitated by Surmap Sdn Bhd, EagleNXT's reseller in Malaysia, includes the eBee TAC, a tactical mapping drone engineered for mission-critical operations, along

    2/12/26 8:00:00 AM ET
    $UAVS
    Aerospace
    Industrials

    Pagaya Reports Fourth Quarter and Full Year Ended 2025 Results

    Reported solid performance across all key metrics: $34 million GAAP Net income; up $272 million YoY $98 million Adjusted EBITDA; up 53% YoY $335 million Total revenue and other income; up 20% YoY $2.7 billion Network volume; up 3% YoY Pagaya Technologies Ltd. (NASDAQ:PGY) ("Pagaya", the "Company" or "we"), a global technology company delivering artificial intelligence infrastructure for the financial ecosystem, today announced financial results for the fourth quarter and full year ended 2025. For additional information, view Pagaya's fourth quarter 2025 letter to shareholders here. "Our fourth quarter and full-year results demonstrate, again, the benefits of years of w

    2/9/26 7:03:00 AM ET
    $PGY
    Finance: Consumer Services
    Finance

    $ACRX
    $AIM
    $AYLA
    $DAVE
    Leadership Updates

    Live Leadership Updates

    View All

    Military UAV Sector Forecast to Surpass $40+ Billion as Modern Warfare Evolves

    NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Unmanned aerial vehicles (UAVs), commonly known as drones, have become a transformative technology in modern defense and military operations, reshaping strategies from reconnaissance to precision strike capabilities. Military drones offer armed forces enhanced situational awareness, reduced risk to personnel, and cost-efficient mission profiles across surveillance, target acquisition, logistics, and electronic warfare. As autonomous systems incorporating artificial intelligence and advanced sensor suites continue to mature, they are increasingly integral to networked battlefield operations and force multiplie

    2/19/26 8:30:00 AM ET
    $NOC
    $PRZO
    $UAVS
    Industrial Machinery/Components
    Industrials
    Military/Government/Technical
    Aerospace

    VNET Appoints New Officer to Finance Leadership Team

    BEIJING, Feb. 13, 2026 /PRNewswire/ -- VNET Group, Inc. (NASDAQ:VNET) ("VNET" or the "Company"), a leading carrier- and cloud-neutral internet data center services provider in China, today announced the appointment of Mr. Peter Zhihua Zhang as Senior Vice President, Operational Finance, effective immediately. Mr. Zhang will be responsible for the Company's financial operations and is authorized to review and approve the Company's financial statements and related filings for SEC and Nasdaq compliance purposes, as applicable. Mr. Zhang will also serve as the Company's "principal accounting officer" in accordance with applicable U.S. federal securities laws, SEC rules, and Nasdaq requirements.

    2/13/26 7:00:00 AM ET
    $VNET
    Computer Software: Programming Data Processing
    Technology

    Dave Inc. Appoints Nima Khajehnouri to Board of Directors; Announces Board Leadership Transitions

    LOS ANGELES, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Dave Inc. ("Dave" or the "Company") (NASDAQ:DAVE), one of the nation's leading neobanks, today announced that Nima Khajehnouri, a distinguished leader in artificial intelligence and data engineering, has joined its Board of Directors, effective immediately. Mr. Khajehnouri will serve as a member of the Company's Audit Committee. Imran Khan, who has served on the Board since August 2023, is stepping down in conjunction with this appointment. Mr. Khajehnouri brings more than two decades' experience of leading engineering at some of the world's most influential technology companies. He currently serves as Vice President of Engineering at Meta, h

    1/20/26 5:27:46 PM ET
    $DAVE
    Finance: Consumer Services
    Finance

    $ACRX
    $AIM
    $AYLA
    $DAVE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by AIM ImmunoTech Inc.

    SC 13D/A - AIM ImmunoTech Inc. (0000946644) (Subject)

    12/17/24 4:11:23 PM ET
    $AIM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by MacroGenics Inc.

    SC 13G - MACROGENICS INC (0001125345) (Subject)

    11/20/24 10:44:27 AM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by AMTD Digital Inc.

    SC 13G/A - AMTD Digital Inc. (0001809691) (Subject)

    11/14/24 9:33:22 PM ET
    $HKD
    Finance: Consumer Services
    Finance